Sintilimab in the Treatment of Advanced and Refractory Pediatric Malignant Tumors
Clinical trial NCT04400851 · UNKNOWN
Trial details
- NCT number
- NCT04400851
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-11
- Primary completion
- 2021-10-10
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.